Neutropenia:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Neutropenia Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Neutropenia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Neutropenia 23
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Neutropenia Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Merck & Co., Inc. 31
Clinical Trial Overview of Merck & Co., Inc. 31
Pfizer Inc. 32
Clinical Trial Overview of Pfizer Inc. 32
Amgen Inc. 33
Clinical Trial Overview of Amgen Inc. 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Teva Pharmaceutical Industries Limited 35
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 35
Johnson & Johnson 36
Clinical Trial Overview of Johnson & Johnson 36
Intas Pharmaceuticals Ltd. 37
Clinical Trial Overview of Intas Pharmaceuticals Ltd. 37
Hanmi Science Co., Ltd. 38
Clinical Trial Overview of Hanmi Science Co., Ltd. 38
Dong-A Socio Holdings Co Ltd 39
Clinical Trial Overview of Dong-A Socio Holdings Co Ltd 39
Apotex, Inc. 40
Clinical Trial Overview of Apotex, Inc. 40
Clinical Trial Overview of Top Institutes / Government 41
National Cancer Institute 41
Clinical Trial Overview of National Cancer Institute 41
National Heart, Lung, and Blood Institute 42
Clinical Trial Overview of National Heart, Lung, and Blood Institute 42
The University of Texas M. D. Anderson Cancer Center 43
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 43
Assistance Publique – Hopitaux de Paris 44
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 44
University of California, San Francisco 45
Clinical Trial Overview of University of California, San Francisco 45
Children’s Oncology Group 46
Clinical Trial Overview of Children’s Oncology Group 46
Wake Forest University 47
Clinical Trial Overview of Wake Forest University 47
European Organization for Research and Treatment of Cancer 48
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 48
Iwate Medical University 49
Clinical Trial Overview of Iwate Medical University 49
Center for Supporting Hematology-Oncology Trials 50
Clinical Trial Overview of Center for Supporting Hematology-Oncology Trials 50
Five Key Clinical Profiles 51
Abbreviations 91
Definitions 91
Research Methodology 92
Secondary Research 92
About GlobalData 92
Contact Us 93
Disclaimer 93
Source 93


【レポート販売概要】

■ タイトル:Neutropenia:グローバル臨床試験レビューH2, 2013
■ 英文:Neutropenia Global Clinical Trials Review, H2, 2013
■ 発行日:2013年11月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162946
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。